Monte Rosa Therapeutics Statistics
NASDAQ: GLUEHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
8.64-0.27 (-3.03%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Monte Rosa Therapeutics by the numbers
Monte Rosa Therapeutics has a market capitalization of $738.3 million based on 85.45M shares outstanding. With trailing EPS of $-1.39, Monte Rosa Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 19.9% below its 50-day average and 47.5% below its 200-day average.
Average daily trading volume is 1.37M shares, or about $11.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
GLUE valuation vs. peer median
| Metric | GLUE | Peer median | Difference |
|---|---|---|---|
| Market cap | $738.29M | $747.44M | -1% |
| Avg. volume | 1.37M | 776.09K | +76% |
Peer median across 8 companies: AURA, SLDB, MGTX, ATTO, PRME, BBTX, ODTX, IAM.
Valuation
- Market cap
- $738.29M
- Price / sales (latest FY)
- 5.97
- EPS (TTM)
- $-1.39
- Shares outstanding
- 85.45M
Price and trading
- Previous close
- 8.91
- Open
- 8.73
- Day range
- 8.48 – 9.04
- 52-week range
- 8.48 – 25.77
- 52-week change
- -39.24%
- Beta
- —
- Volume
- 2.52M
- Average volume
- 1.37M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 738.29M
- Forward Pe
- -4.95
- Eps
- -1.39
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 25.77
- Week52 Low
- 8.48
- Avg Volume
- 1.37M
- Shares Outstanding
- 85.45M
- Ma50
- 10.78
- Ma200
- 16.46
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -66.47%
- Pct From52w Low
- 1.89%